Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharma | 507789

Live

₹232.77

+₹0.88 (+0.38%)

As on 10/07/26, 7:02 PM

Market Cap1,526.66 CR

Current Price₹232.77

High / Low₹301.65 / 155

PE Ratio---

Book Value₹---

Dividend Yield---

ROCE---

ROE18.58%

Face Value₹2.00

Current Vol.54,531

Average Vol.---

ISININE048B01035

PB Ratio---

Debt to Equity---

Net Profit Margin---

Operating Margin---

Share Price Chart - Jagsonpal Pharmaceuticals Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹231.89₹232.3

₹232.77

Previous CloseToday's Open

₹155₹301.65

₹232.77

52W Low52W High

₹232.3Today's Open

₹231.89Previous Close

54,531Volume

₹15552W Low

₹301.6552W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd
The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product
In 1994, the company has also promoted Aresco Financial Services, a new financial company
The Company's R&D activities have resulted in manufacturing process upgradation, improving packaging, and cost containment
It's R&D activities are geared towards development of new product technologies which can be commercialised in future
It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia
In the fiscal 2001, the company's sales grew by 15% to Rs 136

Ethics: Jagsonpal Pharmaceuticals Ltd is flagged for

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI59.30

SMA 20224.89

SMA 50213.90

SMA 100198.46

SMA 200201.10

SMA 10233.78

MACD_12_26_Days7.34

EMA10Day231.76

EMA20Day226.16

EMA50Day214.95

MACD_12_26_9_Days0.04

EMA100Day206.87

EMA200Day205.50

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
INFINITY PORTFOLIO HOLDINGS	13 Sept ‘24	Purchase	22,00,000	₹400	851.62%
INFINITY HOLDINGS	13 Sept ‘24	Sell	22,00,000	₹400	851.62%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

08 May 2026

Buyback

Tender Offer - Max Price: ₹250, Amount: ₹40Cr

12 Mar 2026

24 Sept 2025

AGM

26 Jul 2025

12 Sept 2025

Final Dividend (₹2.5)

The Board recommended a dividend of Rs. 2.5/- (125%) per equity share having face value of Rs. 2 for the financial year ended March 31, 2025. The 46th Annual General Meeting of the company will be held on September 24, 2025. The company has fixed September 12, 2025 as a Record Date for determining eligibility of shareholders for payment of Dividend. (As Per BSE Announcement Dated on :26.07.2025)

06 May 2025

08 Jan 2025

Stock Split (1:2.5)

Face Value Change from 5 To 2

23 Oct 2024

18 Sept 2024

AGM

07 Aug 2024

06 Sept 2024

Final Dividend (₹5)

Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Audited (Standalone) Financial Results for the quarter and year ended March 31, 2024. In this regard, kindly find enclosed the following: 1.The Board recommended a dividend of Rs. 5/- (100%) per equity share for the financial year ended March 31, 2024.

20 May 2024

31 Aug 2023

AGM

05 Aug 2023

21 Aug 2023

Final Dividend (₹5)

The Board of Directors at their meeting held today have recommended dividend of Rs. 5/- per equity share of face value of Rs. 5/- for the financial year ended March 31, 2023. The dividend shall be payable after it is approved by the shareholders at the 44th Annual General Meeting of the Company. Pursuant to Regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has fixed Monday, August 21, 2023, as the Record Date for determining the entitlement of Members to dividend for the financial year ended March 31, 2023. (As Per BSE Announcement Dated on 08.08.2023)

23 May 2023

14 Sept 2022

AGM

24 Aug 2022

17 Jun 2022

EGM

20 May 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
232			0
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 135 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Jagsonpal Pharmaceuticals Ltd?

The current share price of Jagsonpal Pharmaceuticals Ltd (Jagsonpal Pharma) is ₹232.77. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Jagsonpal Pharmaceuticals Ltd?

Jagsonpal Pharmaceuticals Ltd has a 52-week high of ₹301.65 and a 52-week low of ₹155.00. This range shows the stock's price volatility over the past year.

What is the ROE of Jagsonpal Pharmaceuticals Ltd?

Jagsonpal Pharmaceuticals Ltd has a Return on Equity (ROE) of 18.58%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video